Skip to main content
Premium Trial:

Request an Annual Quote

Robbing Peter to Pay Paul

NIH managers aren't following the advice of review panels and are "giving hundreds of millions of dollars a year to scientists," namely young investigators, "whose projects are deemed less scientifically worthy than those denied money," says the New York Times. From a Government Accountability Office report, the Times says that 19 percent of awarded grants made in 2007 were exceptions, and is nearly double the 2003 level.

"I see the value of providing more opportunities to our graduates," Federation of American Societies for Experimental Biology President Mark Lively says. "There's an important need to create openings for those individuals."

The American Society for Biochemistry and Molecular Biology's Peter Farnham, says it's too much. "At 19 percent, they're taking too much from the more seasoned investigators,” he says. "We would be comfortable with a somewhat lower level."

NIH says that all the funded grants are deserving. "By reaching down, we're not sacrificing the quality of the science but instead reaching new investigators," says Sally Rockey, the acting director for extramural research. "We have a far greater amount of high-quality science projects than we could ever fund."

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.